Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Travere Therapeutics Inc (TVTX)
Travere Therapeutics Inc (TVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,225,063
  • Shares Outstanding, K 74,608
  • Annual Sales, $ 212,020 K
  • Annual Income, $ -278,480 K
  • 60-Month Beta 0.46
  • Price/Sales 5.74
  • Price/Cash Flow N/A
  • Price/Book 6.47
Trade TVTX with:

Options Overview Details

View History
  • Implied Volatility 56.08% ( -3.14%)
  • Historical Volatility 112.71%
  • IV Percentile 10%
  • IV Rank 7.00%
  • IV High 156.80% on 02/14/23
  • IV Low 48.49% on 06/06/22
  • Put/Call Vol Ratio 0.05
  • Today's Volume 219
  • Volume Avg (30-Day) 600
  • Put/Call OI Ratio 1.48
  • Today's Open Interest 14,122
  • Open Int (30-Day) 16,563

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -1.16
  • Number of Estimates 7
  • High Estimate -0.97
  • Low Estimate -1.30
  • Prior Year -1.05
  • Growth Rate Est. (year over year) -10.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.51 +13.09%
on 05/02/23
22.75 -27.87%
on 05/01/23
-5.16 (-23.92%)
since 04/28/23
3-Month
14.51 +13.09%
on 05/02/23
23.17 -29.19%
on 04/03/23
-5.75 (-25.95%)
since 02/28/23
52-Week
14.51 +13.09%
on 05/02/23
29.14 -43.69%
on 08/08/22
-7.59 (-31.63%)
since 05/27/22

Most Recent Stories

More News
Ligand (LGND) Up 3% on Raised '23 View, Beats on Q1 Earnings

Ligand Pharmaceuticals (LGND) announces better-than-expected results in first-quarter 2023. Management raises 2023 financial outlook.

LGND : 69.53 (-3.60%)
VKTX : 20.64 (-3.14%)
TVTX : 16.41 (-0.06%)
OABI : 4.31 (+1.41%)
Ligand Reports First Quarter 2023 Financial Results

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today reported financial results for the three months ended March 31, 2023, and provided an operating forecast and business updates. Ligand management...

LGND : 69.53 (-3.60%)
TVTX : 16.41 (-0.06%)
VKTX : 20.64 (-3.14%)
NOVN : 1.1900 (+3.48%)
NVS : 96.55 (-1.34%)
ANEB : 2.38 (+0.85%)
Techne (TECH) Meets Q3 Earnings Estimates

Techne (TECH) delivered earnings and revenue surprises of 0% and 0.74%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

TECH : 83.18 (-0.38%)
TVTX : 16.41 (-0.06%)
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Travere Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Travere Therapeutics, Inc. (“Travere” or “the Company”)...

TVTX : 16.41 (-0.06%)
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Travere Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Travere Therapeutics, Inc. (“Travere” or “the Company”)...

TVTX : 16.41 (-0.06%)
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know

Amicus Therapeutics (FOLD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FOLD : 11.19 (+0.72%)
TVTX : 16.41 (-0.06%)
Bristol Myers Squibb (BMY) Surpasses Q1 Earnings Estimates

Bristol Myers (BMY) delivered earnings and revenue surprises of 3.54% and 2.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BMY : 63.71 (-0.17%)
TVTX : 16.41 (-0.06%)
3 Up-and-Coming Growth Stocks to Buy Right Now

These companies are small now but could grow much larger over time.

AXSM : 69.45 (-0.50%)
SRPT : 124.82 (-1.58%)
TVTX : 16.41 (-0.06%)
3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing

The high-flyers have soared to new heights and further gains could be up ahead.

TVTX : 16.41 (-0.06%)
RETA : 89.70 (-2.83%)
CALT : 17.18 (-3.70%)
NEO : 17.02 (-1.45%)
Could an FDA Approval Send This Stock Flying?

Is now the time to load up on this struggling stock?

TVTX : 16.41 (-0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Travere Therapeutics Inc. is a biopharmaceutical company. It engages to identify, develop and deliver life-changing therapies. Travere Therapeutics Inc., formerly known as Retrophin Inc., is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 17.46
2nd Resistance Point 17.14
1st Resistance Point 16.77
Last Price 16.41
1st Support Level 16.08
2nd Support Level 15.76
3rd Support Level 15.39

See More

52-Week High 29.14
Fibonacci 61.8% 23.55
Fibonacci 50% 21.83
Fibonacci 38.2% 20.10
Last Price 16.41
52-Week Low 14.51

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar